Aligos Therapeutics Company
Aligos Therapeutics is discovering and developing new classes of molecules that interact directly with disease-causing modalities.
Technology:
Others
Industry:
PharmTech
Headquarters:
San Francisco, California, United States
Founded Date:
2018
Employees Number:
1-10
Funding Status:
IPO
Estimated Revenue:
$1M to $10M
Register and Claim Ownership